Finally, PTK787 treatment inhibited the invasiveness and proliferation of CRC cells and increased the levels of apoptosis-associated proteins, suggesting that suppressing the VEGF/VEGFR2 pathway could also hinder the development of CRC cells. This evidence concerns the gene VEGFA and colorectal carcinoma.